Find clinical trials for Chronic Lymphocytic Leukemia in Columbus, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Chronic Lymphocytic Leukemia trials near Columbus, OH, USA:
The primary objective of the study for Cohort 1 and Cohort 2 is to assess the anticancer activity of emavusertib in combination with zanubrutinib in...
Phase 2
Columbus, Ohio, United States and 10 other locations
This phase II trial tests how well nemtabrutinib and venetoclax work in treating patients with chronic lymphocytic leukemia...
Phase 2
Columbus, Ohio, United States
and preliminary efficacy of ZE50-0134 in relapsed and refractory chronic lymphocytic leukemia, small lymphocytic ...
Phase 1
Columbus, Ohio, United States and 3 other locations
Chronic lymphocytic leukemia (CLL) is the most common leukemia (cancer of blood cells). The purpose of this study...
Phase 2
Columbus, Ohio, United States and 57 other locations
This study is evaluating the safety and efficacy of the combined use of acalabrutinib and ACP-319, for the treatment of chronic lymphocytic...
Phase 1
Columbus, Ohio, United States and 2 other locations
The main goal of this study is to show that people with certain immune problems (from Chronic Lymphocytic Leukemia, Multip...
Phase 3
Columbus, Ohio, United States and 4 other locations
This study is evaluating the safety and efficacy of a new BTK inhibitor, acalabrutinib, for the treatment of chronic lymphocytic le...
Phase 1, Phase 2
Columbus, Ohio, United States and 11 other locations
Study J2N-MC-JZ01 (JZ01) is an individual-study appendix (ISA) under master protocol J2N-MC-JZNY, and represents participants from the completed orig...
Phase 4
Columbus, Ohio, United States and 34 other locations
monotherapy in participants with relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) or small lymphocytic...
Phase 1
Columbus, Ohio, United States and 31 other locations
This study is designed to evaluate progression-free survival (PFS) endpoint for acalabrutinib versus (vs) ibrutinib in previously treated chronic...
Phase 3
Columbus, Ohio, United States and 129 other locations
Clinical trials
Research sites
Resources
Legal